Patent details

EP2880036 Title: PIPERAZINO[1,2-A]INDOL-1-ONES AND [1,4]DIAZEPINO[1,2-A]INDOL-1-ONE

Basic Information

Publication number:
EP2880036
PCT Application Number:
EP2013066344
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP137456489
PCT Publication Number:
WO2014023674
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PIPERAZINO[1,2-A]INDOL-1-ONES AND [1,4]DIAZEPINO[1,2-A]INDOL-1-ONE
French Title of Invention:
PIPÉRAZINO[1,2-A]INDOL-1-ONES ET [1,4]DIAZÉPINO[1,2-A]INDOL-1-ONE
German Title of Invention:
PIPERAZIN[1,2-A-]INDOL-1-ONE UND [1,4-]DIAZEPIN[1,2-A-]INDOL-1-ON
SPC Number:

Dates

Filing date:
05/08/2013
Grant date:
08/03/2017
EP Publication Date:
10/06/2015
PCT Publication Date:
13/02/2014
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
08/03/2017
EP B1 Publication Date:
08/03/2017
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
05/08/2017
Expiration date:
05/08/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
08/03/2017
 
 

Name:
F. Hoffmann-La Roche AG
Address:
Grenzacherstrasse 124, 4070 Basel, Switzerland (CH)

Inventor

1

Name:
JAKOB-ROETNE, Roland
Address:
Germany (DE)

2

Name:
JAGASIA, Ravi
Address:
Germany (DE)

3

Name:
WICHMANN, Juergen
Address:
Germany (DE)

4

Name:
CECCARELLI, Simona M.
Address:
Switzerland (CH)

Priority

Priority Number:
12179381
Priority Date:
06/08/2012
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
A61K 31/4985; A61P 25/00; C07D 487/04;

Publication

European Patent Bulletin

Issue number:
201710
Publication date:
08/03/2017
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
31/12/2017 Outgoing Correspondence 1